324 related articles for article (PubMed ID: 34047814)
21. Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver disease.
Min HK; Mirshahi F; Verdianelli A; Pacana T; Patel V; Park CG; Choi A; Lee JH; Park CB; Ren S; Sanyal AJ
Am J Physiol Gastrointest Liver Physiol; 2015 May; 308(9):G794-803. PubMed ID: 25747354
[TBL] [Abstract][Full Text] [Related]
22. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
Klein C; Wüstefeld T; Assmus U; Roskams T; Rose-John S; Müller M; Manns MP; Ernst M; Trautwein C
J Clin Invest; 2005 Apr; 115(4):860-9. PubMed ID: 15761498
[TBL] [Abstract][Full Text] [Related]
23. Lack of interleukin-6/glycoprotein 130/signal transducers and activators of transcription-3 signaling in hepatocytes predisposes to liver steatosis and injury in mice.
Kroy DC; Beraza N; Tschaharganeh DF; Sander LE; Erschfeld S; Giebeler A; Liedtke C; Wasmuth HE; Trautwein C; Streetz KL
Hepatology; 2010 Feb; 51(2):463-73. PubMed ID: 19918973
[TBL] [Abstract][Full Text] [Related]
24. Drug-induced modulation of gp130 signalling prevents articular cartilage degeneration and promotes repair.
Shkhyan R; Van Handel B; Bogdanov J; Lee S; Yu Y; Scheinberg M; Banks NW; Limfat S; Chernostrik A; Franciozi CE; Alam MP; John V; Wu L; Ferguson GB; Nsair A; Petrigliano FA; Vangsness CT; Vadivel K; Bajaj P; Wang L; Liu NQ; Evseenko D
Ann Rheum Dis; 2018 May; 77(5):760-769. PubMed ID: 29436471
[TBL] [Abstract][Full Text] [Related]
25. Influence of digital hypothermia on lamellar events related to IL-6/gp130 signalling in equine sepsis-related laminitis.
Dern K; Burns TA; Watts MR; van Eps AW; Belknap JK
Equine Vet J; 2020 May; 52(3):441-448. PubMed ID: 31509270
[TBL] [Abstract][Full Text] [Related]
26. Cytokine signalling by gp130 regulates gastric mucosal healing after ulceration and, indirectly, antral tumour progression.
Judd LM; Ulaganathan M; Howlett M; Giraud AS
J Pathol; 2009 Mar; 217(4):552-62. PubMed ID: 19097069
[TBL] [Abstract][Full Text] [Related]
27. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3.
Greenhill CJ; Rose-John S; Lissilaa R; Ferlin W; Ernst M; Hertzog PJ; Mansell A; Jenkins BJ
J Immunol; 2011 Jan; 186(2):1199-208. PubMed ID: 21148800
[TBL] [Abstract][Full Text] [Related]
28. LPS hypersensitivity of gp130 mutant mice is independent of elevated haemopoietic TLR4 signaling.
Greenhill CJ; Gould J; Ernst M; Jarnicki A; Hertzog PJ; Mansell A; Jenkins BJ
Immunol Cell Biol; 2012 May; 90(5):559-63. PubMed ID: 21670738
[TBL] [Abstract][Full Text] [Related]
29. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
30. Imbalanced gp130 signalling in ApoE-deficient mice protects against atherosclerosis.
Jones GW; McLeod L; Kennedy CL; Bozinovski S; Najdovska M; Jenkins BJ
Atherosclerosis; 2015 Feb; 238(2):321-8. PubMed ID: 25545330
[TBL] [Abstract][Full Text] [Related]
31. Breast Cancer-Derived Exosomes Alter Macrophage Polarization
Ham S; Lima LG; Chai EPZ; Muller A; Lobb RJ; Krumeich S; Wen SW; Wiegmans AP; Möller A
Front Immunol; 2018; 9():871. PubMed ID: 29867925
[TBL] [Abstract][Full Text] [Related]
32. STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroid hormone.
O'Brien CA; Gubrij I; Lin SC; Saylors RL; Manolagas SC
J Biol Chem; 1999 Jul; 274(27):19301-8. PubMed ID: 10383440
[TBL] [Abstract][Full Text] [Related]
33. IL-6/Stat3-driven pulmonary inflammation, but not emphysema, is dependent on interleukin-17A in mice.
Ruwanpura SM; McLeod L; Brooks GD; Bozinovski S; Vlahos R; Longano A; Bardin PG; Anderson GP; Jenkins BJ
Respirology; 2014 Apr; 19(3):419-27. PubMed ID: 24506702
[TBL] [Abstract][Full Text] [Related]
34. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
Hirano T; Ishihara K; Hibi M
Oncogene; 2000 May; 19(21):2548-56. PubMed ID: 10851053
[TBL] [Abstract][Full Text] [Related]
35. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells.
Kim H; Hawley TS; Hawley RG; Baumann H
Mol Cell Biol; 1998 Mar; 18(3):1525-33. PubMed ID: 9488469
[TBL] [Abstract][Full Text] [Related]
36. Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130/STAT3 signaling pathway.
Kuang Y; Guo W; Ling J; Xu D; Liao Y; Zhao H; Du X; Wang H; Xu M; Song H; Wang T; Jing B; Li K; Hu M; Wu W; Deng J; Wang Q
Cell Death Dis; 2019 Apr; 10(4):297. PubMed ID: 30931929
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-6 and its receptors: a highly regulated and dynamic system.
Wolf J; Rose-John S; Garbers C
Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424
[TBL] [Abstract][Full Text] [Related]
38. Discovery of a novel orally active small-molecule gp130 inhibitor for the treatment of ovarian cancer.
Xu S; Grande F; Garofalo A; Neamati N
Mol Cancer Ther; 2013 Jun; 12(6):937-49. PubMed ID: 23536726
[TBL] [Abstract][Full Text] [Related]
39. Opposing roles of gp130-mediated STAT-3 and ERK-1/ 2 signaling in liver progenitor cell migration and proliferation.
Yeoh GC; Ernst M; Rose-John S; Akhurst B; Payne C; Long S; Alexander W; Croker B; Grail D; Matthews VB
Hepatology; 2007 Feb; 45(2):486-94. PubMed ID: 17256754
[TBL] [Abstract][Full Text] [Related]
40. Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.
Wu X; Cao Y; Xiao H; Li C; Lin J
Mol Cancer Ther; 2016 Nov; 15(11):2609-2619. PubMed ID: 27535971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
